Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

20.86

-0.15 (-0.71%)

At close: May 22, 2026, 4:00 PM EDT

20.56

-0.30 (-1.42%)

After-hours: May 22, 2026, 7:52 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
ZORYVE Cream 0.3% Revenue	130.28M	121.00M	85.08M
ZORYVE Cream 0.3% Revenue Growth	7.67%	42.21%	191.52%
ZORYVE Foam Revenue	201.28M	181.89M	71.54M
ZORYVE Foam Revenue Growth	10.66%	154.26%	-
ZORYVE Cream 0.15% Revenue	79.80M	68.27M	9.92M
ZORYVE Cream 0.15% Revenue Growth	16.88%	588.18%	-
ZORYVE Cream 0.05% Revenue	-	911.00K	-
Total Product Revenue	413.62M	372.07M	166.54M
Total Product Revenue Growth	11.17%	123.41%	470.62%
Other Segment Revenue	-	4.00M	30.00M
Other Segment Revenue Growth	-	-86.67%	-1.38%
Revenue (Other)	2.00M	-911.00K	-
Revenue (Total)	415.62M	376.07M	196.54M
Revenue (Total) Growth	10.52%	91.34%	229.73%

Updated May 6, 2026. Data Source: Fiscal.ai.